Durham biotech firm IMMvention Therapeutix brings in $2M
Durham-headquartered IMMvention Therapeutix has raised nearly $2 million in new funding, according to a securities filing.
Read More
immvention therapeutix
Triangle startup developing therapies to fight inflammation lands $3.9M from investors
IMMvention Therapeutix, which nearly won a pitch competition from LaunchBio this summer, has won a bigger deal with investors. We’ve got the details.
Read More
Durham life science startup IMMvention shines in LaunchBio Big Pitch competition
IMMvention Therapeutix almost hit The Big Pitch out of the park. Almost.
Read More
5 NC startups advance in LaunchBio’s national pitch event
Five NC startups advance in LaunchBio’s national pitch competition. Here’s a look at the emerging firms.
Read More
